Immunogenicity 13214
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CAPN7
Transcript ID
uc003bzn.3
HLA INFO
C*02:02
TCR INFO
No TCR info found!
Full length protein sequence (813 aa)
MDATA
1
LERDA
6
VQFAR
11
LAVQR
16
DHEGR
21
YSEAV
26
FYYKE
31
AAQAL
36
IYAEM
41
AGSSL
46
ENIQE
51
KITEY
56
LERVQ
61
ALHSA
66
VQSKS
71
ADPLK
76
SKHQL
81
DLERA
86
HFLVT
91
QAFDE
96
DEKEN
101
VEDAI
106
ELYTE
111
AVDLC
116
LKTSY
121
ETADK
126
VLQNK
131
LKQLA
136
RQALD
141
RAEAL
146
SEPLT
151
KPVGK
156
ISSTS
161
VKPKP
166
PPVRA
171
HFPLG
176
ANPFL
181
ERPQS
186
FISPQ
191
SCDAQ
196
GQRYT
201
AEEIE
206
VLRTT
211
SKING
216
IEYVP
221
FMNVD
226
LRERF
231
AYPMP
236
FCDRW
241
GKLPL
246
SPKQK
251
TTFSK
256
WVRPE
261
DLTNN
266
PTMIY
271
TVSSF
276
SIKQT
281
IVSDC
286
SFVAS
291
LAISA
296
AYERR
301
FNKKL
306
ITGII
311
YPQNK
316
DGEPE
321
YNPCG
326
KYMVK
331
LHLNG
336
VPRKV
341
IIDDQ
346
LPVDH
351
KGELL
356
CSYSN
361
NKSEL
366
WVSLI
371
EKAYM
376
KVMGG
381
YDFPG
386
SNSNI
391
DLHAL
396
TGWIP
401
ERIAM
406
HSDSQ
411
TFSKD
416
NSFRM
421
LYQRF
426
HKGDV
431
LITAS
436
TGMMT
441
EAEGE
446
KWGLV
451
PTHAY
456
AVLDI
461
REFKG
466
LRFIQ
471
LKNPW
476
SHLRW
481
KGRYS
486
ENDVK
491
NWTPE
496
LQKYL
501
NFDPR
506
TAQKI
511
DNGIF
516
WISWD
521
DLCQY
526
YDVIY
531
LSWNP
536
GLFKE
541
STCIH
546
STWDA
551
KQGPV
556
KDAYS
561
LANNP
566
QYKLE
571
VQCPQ
576
GGAAV
581
WVLLS
586
RHITD
591
KDDFA
596
NNREF
601
ITMVV
606
YKTDG
611
KKVYY
616
PADPP
621
PYIDG
626
IRINS
631
PHYLT
636
KIKLT
641
TPGTH
646
TFTLV
651
VSQYE
656
KQNTI
661
HYTVR
666
VYSAC
671
SFTFS
676
KIPSP
681
YTLSK
686
RINGK
691
WSGQS
696
AGGCG
701
NFQET
706
HKNNP
711
IYQFH
716
IEKTG
721
PLLIE
726
LRGPR
731
QYSVG
736
FEVVT
741
VSTLG
746
DPGPH
751
GFLRK
756
SSGDY
761
RCGFC
766
YLELE
771
NIPSG
776
IFNII
781
PSTFL
786
PKQEG
791
PFFLD
796
FNSII
801
PIKIT
806
QLQ
811
Mutation Information
DNA mutation:
None
Peptide Range:
794 ~ 813
Mut AA position:
806 (13 in Wild Type peptide)
Alignment
Wild Type:
"EGPFFLDFNSIIPIKITQLQ
||||||||||||.|||||||
Mutant:
EGPFFLDFNSIISIKITQLQ"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CAPN7
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay